Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Schwabl, Philipp
Item TypeName
Academic Article Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Academic Article Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.
Concept Liver Cirrhosis, Experimental
Concept Liver Cirrhosis
Academic Article Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Academic Article ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Academic Article Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.
Academic Article Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.
Academic Article Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
Academic Article Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna.
Academic Article Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
Academic Article Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
Academic Article Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.
Academic Article Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
Academic Article Nonselective ß blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Academic Article Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Academic Article The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.
Academic Article Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP).
Academic Article Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
Academic Article The impact of hepatic steatosis on portal hypertension.
Academic Article Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.
Academic Article Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Academic Article Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Academic Article Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Academic Article The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Academic Article Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
Academic Article Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
Academic Article Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Academic Article Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis.
Academic Article Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.
Academic Article The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.
Academic Article Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Academic Article Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.
Academic Article Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Academic Article Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
Academic Article PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
Academic Article Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats.
Academic Article Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.
Academic Article Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis.
Academic Article Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Academic Article Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
Search Criteria
  • Liver Fibrosis
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.